BioSpace News Archive

BioForest

Millennial Generation Deaths Due to Drug Misuse up 400 percent since 1999; Deaths from Drugs and Suicide at All-time Highs

New report provides solutions for stopping deaths of despair among Millennials

June 13, 2019
·
5 min read
Business

AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease

AbCellera, a leader in therapeutic antibody discovery from natural immune systems, announced it has entered into an agreement with Gilead Sciences to support the discovery of therapeutic antibody candidates for infectious diseases.

June 13, 2019
·
2 min read
Drug Development

First-in-Human Data Presented from Phase 1a Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology

Nektar Therapeutics announced the results of the first-in-human Phase 1a study evaluating single-ascending doses of NKTR-358, a first-in-class T regulatory cell stimulator in clinical development for the treatment of autoimmune and other chronic inflammatory conditions.

June 13, 2019
·
7 min read
Pharm Country

Soligenix to Present RiVax® Program at the 13ᵗʰ Annual CounterACT Network Research Symposium

Soligenix, Inc. announced that Dr. Oreola Donini, Chief Scientific Officer, will be presenting data from the ricin toxin vaccine (RiVax®) program describing development of the vaccine under the Food and Drug Administration (FDA) Animal Rule.

June 13, 2019
·
10 min read
Genetown

Tetraphase Pharmaceuticals Highlights Data at Upcoming American Society for Microbiology Microbe 2019 Annual Meeting

Tetraphase Pharmaceuticals, Inc. announced that new data will be presented at the American Society for Microbiology Microbe 2019 Annual Meeting, taking place June 20-24 in San Francisco.

June 13, 2019
·
8 min read
BioForest

CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Thursday, Jun. 20

CTI BioPharma Corp. announced that management will provide a corporate overview at the JMP Securities Life Sciences Conference at 2:00 p.m. EDT in New York City.

June 13, 2019
·
1 min read
Pharm Country

Newron Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

Newron Pharmaceuticals S.p.A. announced that Stefan Weber, CEO, will be participating on a panel discussion entitled, “Innovative Treatment Approaches to Orphan CNS Developmental Disorders” at the JMP Securities Life Sciences Conference on Wednesday, June 19th, 2019 at 10:00 a.m. EDT.

June 13, 2019
·
2 min read
Policy

First Subject Enrolled in Large, Multi-Center Pivotal Trial to Confirm Safety and Efficacy of TearCare® in the Treatment of Signs and Symptoms of Dry Eye Disease

Sight Sciences, Inc. announced the first subject has been enrolled in OLYMPIA, the U.S. pivotal trial to further assess the safety and efficacy of TearCare® for patients with dry eye disease.

June 13, 2019
·
3 min read
BioCapital

Intrexon’s Subsidiary Precigen to Present at the JMP Securities Life Sciences Conference

Intrexon Corporation and Precigen, Inc. announced their presentation at the JMP Securities Life Sciences Conference in New York.

June 13, 2019
·
3 min read
Business

Elekta Increases Focus on Digitization - Hires Sukhveer Singh to Drive Elekta Digital strategy

Digital solutions are high on the agenda for most industries, especially within healthcare.

June 13, 2019
·
2 min read